242 related articles for article (PubMed ID: 11916790)
1. Neuromuscular pharmacology of TAAC3, a new nondepolarizing muscle relaxant with rapid onset and ultrashort duration of action.
Gyermek L; Lee C; Cho YM; Nguyen N; Tsai SK
Anesth Analg; 2002 Apr; 94(4):879-85, table of contents. PubMed ID: 11916790
[TBL] [Abstract][Full Text] [Related]
2. Pharmacology of G-1-64, a new nondepolarizing neuromuscular blocking agent with rapid onset and short duration of action.
Gyermek L; Lee C; Nguyen N
Acta Anaesthesiol Scand; 1999 Jul; 43(6):651-7. PubMed ID: 10408820
[TBL] [Abstract][Full Text] [Related]
3. Quaternary derivatives of granatanol diesters: potent, ultrashort acting non-depolarizing neuromuscular relaxants.
Gyermek L; Lee C; Cho YM; Nguyen N
Life Sci; 2006 Jul; 79(6):559-69. PubMed ID: 16516930
[TBL] [Abstract][Full Text] [Related]
4. A new short-acting non-depolarizing muscle relaxant (SZ1677) without cardiovascular side-effects.
Vizi ES; Tuba Z; Mahó S; Foldes FF; Nagano O; Dóda M; Takagi S; Chaudhry IA; Saubermann AJ; Nagashima H
Acta Anaesthesiol Scand; 2003 Mar; 47(3):291-300. PubMed ID: 12648195
[TBL] [Abstract][Full Text] [Related]
5. Effects of a new neuromuscular blocking agent (Org 9426) in anaesthetized cats and pigs and in isolated nerve-muscle preparations.
Muir AW; Houston J; Green KL; Marshall RJ; Bowman WC; Marshall IG
Br J Anaesth; 1989 Oct; 63(4):400-10. PubMed ID: 2573387
[TBL] [Abstract][Full Text] [Related]
6. Dose-response relationships for neostigmine antagonism of rocuronium-induced neuromuscular block in children and adults.
Abdulatif M; Mowafi H; al-Ghamdi A; el-Sanabary M
Br J Anaesth; 1996 Dec; 77(6):710-5. PubMed ID: 9014620
[TBL] [Abstract][Full Text] [Related]
7. Dose-response relationships for edrophonium and neostigmine antagonism of rocuronium bromide (ORG 9426)-induced neuromuscular blockade.
Naguib M; Abdulatif M; al-Ghamdi A
Anesthesiology; 1993 Oct; 79(4):739-45. PubMed ID: 8214753
[TBL] [Abstract][Full Text] [Related]
8. Repeat dosing of rocuronium 1.2 mg kg-1 after reversal of neuromuscular block by sugammadex 4.0 mg kg-1 in anaesthetized healthy volunteers: a modelling-based pilot study.
Cammu G; de Kam PJ; De Graeve K; van den Heuvel M; Suy K; Morias K; Foubert L; Grobara P; Peeters P
Br J Anaesth; 2010 Oct; 105(4):487-92. PubMed ID: 20630888
[TBL] [Abstract][Full Text] [Related]
9. An overview of the pharmacology of rocuronium bromide in experimental animals.
Marshall RJ; Muir AW; Sleigh T; Savage DS
Eur J Anaesthesiol Suppl; 1994; 9():9-15. PubMed ID: 7925216
[TBL] [Abstract][Full Text] [Related]
10. Preclinical pharmacology of GW280430A (AV430A) in the rhesus monkey and in the cat: a comparison with mivacurium.
Savarese JJ; Belmont MR; Hashim MA; Mook RA; Boros EE; Samano V; Patel SS; Feldman PL; Schultz JA; McNulty M; Spitzer T; Cohn DL; Morgan P; Wastila WB
Anesthesiology; 2004 Apr; 100(4):835-45. PubMed ID: 15087618
[TBL] [Abstract][Full Text] [Related]
11. Adenosine potentiation of neuromuscular blocking agents in guinea-pigs.
Nitahara K; Kornak P; Nagashima H; Vizi ES; Foldes FF; Dan K
Br J Anaesth; 2000 Feb; 84(2):245-7. PubMed ID: 10743461
[TBL] [Abstract][Full Text] [Related]
12. Effects of SZ1677, a new non-depolarizing steroidal neuromuscular blocking drug, and rocuronium on two laryngeal muscles and the anterior tibial muscle in guinea pigs.
Michalek-Sauberer A; Nicolakis EM; Vizi ES; Gilly H
Acta Anaesthesiol Scand; 2006 Apr; 50(4):481-7. PubMed ID: 16548861
[TBL] [Abstract][Full Text] [Related]
13. Recovery from neuromuscular block after an intubation dose of cisatracurium and rocuronium in lumbar disc surgery.
Hans P; Welter P; Dewandre PY; Brichant JF; Bonhomme V
Acta Anaesthesiol Belg; 2004; 55(2):129-33. PubMed ID: 15264506
[TBL] [Abstract][Full Text] [Related]
14. Neuromuscular blocking effects and train-of-four fade with cisatracurium: comparison with other nondepolarising relaxants.
Carroll MT; Mirakhur RK; Lowry DW; McCourt KC; Kerr C
Anaesthesia; 1998 Dec; 53(12):1169-73. PubMed ID: 10193219
[TBL] [Abstract][Full Text] [Related]
15. Neuromuscular blocking and cardiovascular effects of Org 9487, a new short-acting aminosteroidal blocking agent, in anaesthetized animals and in isolated muscle preparations.
Muir AW; Sleigh T; Marshall RJ; Pow E; Anderson KA; Booij LH; Hill DR
Eur J Anaesthesiol; 1998 Jul; 15(4):467-79. PubMed ID: 9699106
[TBL] [Abstract][Full Text] [Related]
16. Sevoflurane increases fade of neuromuscular response to TOF stimulation following rocuronium administration in children. A PK/PD analysis.
Woloszczuk-Gebicka B; Wyska E; Grabowski T
Paediatr Anaesth; 2007 Jul; 17(7):637-46. PubMed ID: 17564645
[TBL] [Abstract][Full Text] [Related]
17. Newer neuromuscular blocking agents: how do they compare with established agents?
Sparr HJ; Beaufort TM; Fuchs-Buder T
Drugs; 2001; 61(7):919-42. PubMed ID: 11434449
[TBL] [Abstract][Full Text] [Related]
18. Comparative pharmacology of cisatracurium (51W89), atracurium, and five isomers in cats.
Wastila WB; Maehr RB; Turner GL; Hill DA; Savarese JJ
Anesthesiology; 1996 Jul; 85(1):169-77. PubMed ID: 8694363
[TBL] [Abstract][Full Text] [Related]
19. Chemical encapsulation of rocuronium by synthetic cyclodextrin derivatives: reversal of neuromuscular block in anaesthetized Rhesus monkeys.
de Boer HD; van Egmond J; van de Pol F; Bom A; Booij LH
Br J Anaesth; 2006 Feb; 96(2):201-6. PubMed ID: 16377646
[TBL] [Abstract][Full Text] [Related]
20. Sugammadex, a new reversal agent for neuromuscular block induced by rocuronium in the anaesthetized Rhesus monkey.
de Boer HD; van Egmond J; van de Pol F; Bom A; Booij LH
Br J Anaesth; 2006 Apr; 96(4):473-9. PubMed ID: 16464982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
